147 related articles for article (PubMed ID: 20663207)
21. [Effect of vitamin D
Ding F; Zang B; Fu J; Ji K
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):106-110. PubMed ID: 28625255
[TBL] [Abstract][Full Text] [Related]
22. Lack of effect of N-acetylcysteine treatment to ameliorate the progression of multiple organ failure.
Akinci SB; Erden IA; Kanbak M; Aypar U
Saudi Med J; 2005 Apr; 26(4):651-5. PubMed ID: 15900378
[TBL] [Abstract][Full Text] [Related]
23. [Intravenous glutamine and early nasojejunal nutrition in severe acute pancreatitis -- a prospective randomized clinical study].
Hajdú N; Belágyi T; Issekutz A; Bartek P; Gartner B; Oláh A
Magy Seb; 2012 Apr; 65(2):44-51. PubMed ID: 22512878
[TBL] [Abstract][Full Text] [Related]
24. Safety of granulocyte colony-stimulating factor (filgrastim) in intubated patients in the intensive care unit: interim analysis of a prospective, placebo-controlled, double-blind study.
Pettilä V; Takkunen O; Varpula T; Markkola A; Porkka K; Valtonen V
Crit Care Med; 2000 Nov; 28(11):3620-5. PubMed ID: 11098963
[TBL] [Abstract][Full Text] [Related]
25. Activated protein C, an anticoagulant polypeptide, ameliorates severe acute pancreatitis via regulation of mitogen-activated protein kinases.
Chen P; Zhang Y; Qiao M; Yuan Y
J Gastroenterol; 2007 Nov; 42(11):887-96. PubMed ID: 18008033
[TBL] [Abstract][Full Text] [Related]
26. Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
Timsit JF; Azoulay E; Schwebel C; Charles PE; Cornet M; Souweine B; Klouche K; Jaber S; Trouillet JL; Bruneel F; Argaud L; Cousson J; Meziani F; Gruson D; Paris A; Darmon M; Garrouste-Orgeas M; Navellou JC; Foucrier A; Allaouchiche B; Das V; Gangneux JP; Ruckly S; Maubon D; Jullien V; Wolff M;
JAMA; 2016 Oct; 316(15):1555-1564. PubMed ID: 27706483
[TBL] [Abstract][Full Text] [Related]
27. Activated protein C improves the severity of severe acute pancreatitis via up-regulating the expressions of endothelial cell protein C receptor and thrombomodulin.
Ping C; Yongping Z; Minmin Q; Weiyan Y; Yaozong Y
Dig Dis Sci; 2010 Jun; 55(6):1599-609. PubMed ID: 19680809
[TBL] [Abstract][Full Text] [Related]
28. A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation.
Aoki N; Matsuda T; Saito H; Takatsuki K; Okajima K; Takahashi H; Takamatsu J; Asakura H; Ogawa N;
Int J Hematol; 2002 Jun; 75(5):540-7. PubMed ID: 12095157
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of red blood cell distribution width for severe acute pancreatitis.
Zhang FX; Li ZL; Zhang ZD; Ma XC
World J Gastroenterol; 2019 Aug; 25(32):4739-4748. PubMed ID: 31528098
[TBL] [Abstract][Full Text] [Related]
30. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
[TBL] [Abstract][Full Text] [Related]
31. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death.
Abraham E; Laterre PF; Garg R; Levy H; Talwar D; Trzaskoma BL; François B; Guy JS; Brückmann M; Rea-Neto A; Rossaint R; Perrotin D; Sablotzki A; Arkins N; Utterback BG; Macias WL;
N Engl J Med; 2005 Sep; 353(13):1332-41. PubMed ID: 16192478
[TBL] [Abstract][Full Text] [Related]
32. Systemic and organ dysfunction response during infusion of recombinant human activated protein C (rhAPC) in severe sepsis and septic shock.
Gullo A; Iscra F; Di Capua G; Berlot G; Lucangelo U; Peratoner A; Fasiolo S; Viviani M; Consales C; Zicari A
Minerva Anestesiol; 2005 Dec; 71(12):785-801. PubMed ID: 16288186
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of recombinant human activated protein C for severe sepsis.
Bernard GR; Vincent JL; Laterre PF; LaRosa SP; Dhainaut JF; Lopez-Rodriguez A; Steingrub JS; Garber GE; Helterbrand JD; Ely EW; Fisher CJ;
N Engl J Med; 2001 Mar; 344(10):699-709. PubMed ID: 11236773
[TBL] [Abstract][Full Text] [Related]
34. Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial.
Dhainaut JF; Laterre PF; Janes JM; Bernard GR; Artigas A; Bakker J; Riess H; Basson BR; Charpentier J; Utterback BG; Vincent JL;
Intensive Care Med; 2003 Jun; 29(6):894-903. PubMed ID: 12712239
[TBL] [Abstract][Full Text] [Related]
35. Protective effects of baicalin and octreotide on multiple organ injury in severe acute pancreatitis.
Zhang XP; Zhang L; Yang P; Zhang RP; Cheng QH
Dig Dis Sci; 2008 Feb; 53(2):581-91. PubMed ID: 17549629
[TBL] [Abstract][Full Text] [Related]
36. A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome.
Vincent JL; Artigas A; Petersen LC; Meyer C
Crit Care Med; 2009 Jun; 37(6):1874-80. PubMed ID: 19384216
[TBL] [Abstract][Full Text] [Related]
37. Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial.
Beauchant M; Ingrand P; Favriel JM; Dupuychaffray JP; Capony P; Moindrot H; Barthet M; Escourrou J; Plane C; Barrioz T; Lacoste L; Ingrand I
Endoscopy; 2008 Aug; 40(8):631-6. PubMed ID: 18680075
[TBL] [Abstract][Full Text] [Related]
38. [The use of sodium bicarbonate in stages in treating hypoperfusion induced lactic acidemia in septic shock].
Chen XF; Ye JL; Zhu ZY
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jan; 25(1):24-7. PubMed ID: 23611092
[TBL] [Abstract][Full Text] [Related]
39. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis.
Kingsnorth AN; Galloway SW; Formela LJ
Br J Surg; 1995 Oct; 82(10):1414-20. PubMed ID: 7489182
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of iloprost in patients with septic shock-induced endotheliopathy-Protocol for the multicenter randomized, placebo-controlled, blinded, investigator-initiated trial.
Bestle MH; Clausen NE; Søe-Jensen P; Kristiansen KT; Lange T; Johansson PI; Stensballe J; Perner A
Acta Anaesthesiol Scand; 2020 May; 64(5):705-711. PubMed ID: 31950481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
